Debt-to-equity of enVVeno Medical Corp from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
enVVeno Medical Corp quarterly Debt-to-equity in % history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • enVVeno Medical Corp Debt-to-equity for the quarter ending 30 Sep 2025 was 8%, a 34% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

enVVeno Medical Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 8% +2% +34% 30 Sep 2025
Q2 2025 7.2% +0.2% +2.9% 30 Jun 2025
Q1 2025 6.4% -1.6% -20% 31 Mar 2025
Q4 2024 6.4% -2.1% -25% 31 Dec 2024
Q3 2024 6% -3.4% -36% 30 Sep 2024
Q2 2024 7% -0.94% -12% 30 Jun 2024
Q1 2024 8% +0.83% +12% 31 Mar 2024
Q4 2023 8.5% +1.8% +27% 31 Dec 2023
Q3 2023 9.4% +3% +48% 30 Sep 2023
Q2 2023 8% +2.9% +56% 30 Jun 2023
Q1 2023 7.1% +2.8% +66% 31 Mar 2023
Q4 2022 6.7% +2.6% +66% 31 Dec 2022
Q3 2022 6.3% +0.92% +17% 30 Sep 2022
Q2 2022 5.1% -4.5% -47% 30 Jun 2022
Q1 2022 4.3% -16% -79% 31 Mar 2022
Q4 2021 4% -93% -96% 31 Dec 2021
Q3 2021 5.4% -171% -97% 30 Sep 2021
Q2 2021 9.6% -245% -96% 30 Jun 2021
Q1 2021 20% -100% -83% 31 Mar 2021
Q4 2020 97% +7.5% +8.4% 31 Dec 2020
Q3 2020 177% +102% +137% 30 Sep 2020
Q2 2020 254% +188% +285% 30 Jun 2020
Q1 2020 120% +54% +82% 31 Mar 2020
Q4 2019 89% 31 Dec 2019
Q3 2019 74% 30 Sep 2019
Q2 2019 66% 30 Jun 2019
Q1 2019 66% 31 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.